GRP logo
Observational Study Questionnaire for Health Care Decision Making

A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report

The citation for this report is:
Berger M, Martin B, Husereau D, et al, A questionnaire to assess the relevance and credibility of observational studies to inform healthcare decision making: an ISPOR-AMCP-NPC good practice task force report. Value Health 2014; 17:143-156.

Editorial: Tools for Health Care Decision Making: Observational Studies, Modeling Studies, and Network Meta-Analyses

Naomi Aronson, PhD, & Mark D. Grant, MD, PhD, Center for Clinical Effectiveness, Office of Clinical Affairs, Blue Cross Blue Shield Association, Chicago, IL, USA

Webinars Icon ยป Webinar

Assessing Prospective Observational Studies for Health Care Decisions Task Force Leadership Group:
Marc Berger, MD, (Task Force Chair) VP Real World Data and Analytics, Pfizer, New York, NY, USA (ISPOR)
Dan Allen, PharmD, Clinical Pharmacist Consultant, RegenceRx, Portland, OR, USA (AMPC)
Karen Worley, PhD, Research Leader Comprehensive Health Insights, Humana, Inc., Cincinnati, OH, USA (AMPC)
Scott Devine, MPH, PhD, Outcomes Research Scientist, US Outcomes Research, Merck & Co, Inc., St. Louis, MO, USA (NPC)
John Graham, PharmD, Group Director, Health Services, US Medical, Bristol-Myers Squibb, Princeton, NJ, USA (NPC)
Don Husereau, BScPharm, MSc, Adjunct Professor, Faculty of Medicine, University of Ottawa and Senior Scientist, University for Health Sciences, Medical Informatics and Technology, Tirol, Austria, Ottawa, ON, Canada (ISPOR)
C. Daniel Mullins, PhD, Professor, University of Maryland School of Pharmacy, Baltimore, MD, USA (ISPOR)

Assessing Retrospective Observational Studies for Health Care Decisions Task Force Leadership Group:
Bradley Martin PhD, RPh, PharmD, (Task Force Chair) Professor and Division Chair, College of Pharmacy, University of Arkansas for Medical Sciences, Department of Pharmacy Practice, Little Rock, AR, USA, (ISPOR)
Winnie Yang, PharmD, Director, Pharmacy Product, Strategy and Analytics Blue Shield of California Woodland Hills, CA, USA (AMCP)
Eric Cannon, PharmD, FAMCP, Chief of Pharmacy SelectHealth, Murray, Utah, USA (AMCP)
Kristijan Kahler, PhD, RPh, Head, HEOR Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA (NPC)
Nicole C. Quon, PhD, Senior Director, Healthcare Quality, Optimer Pharmaceuticals, Inc. Jersey City, NJ, USA (NPC)
William Crown, PhD, Senior Scientific Officer, OptumLabs, Cambridge, MA USA (ISPOR)
Michael Johnson, PhD, Associate Professor University of Houston, College of Pharmacy, Houston, TX , USA (ISPOR)

Report Comments:
Prospective Observational Studies and Retrospective Observational Studies.

Task Force Activities:
ASSESSING THE EVIDENCE FOR THE HEALTH CARE DECISION MAKER
May 22nd 2013 – 18th Annual International Meeting, Third Plenary Session, New Orleans, LA

HEALTH EVIDENCE FOR DECISION MAKING: ASSESSMENT TOOL FOR PROSPECTIVE AND RETROSPECTIVE OBSERVATIONAL STUDIES
November 5th, 2012 – 15th Annual European Congress, ISPOR Forum Presentation, Berlin, Germany

ASSESSING RETROSPECTIVE OBSERVATIONAL STUDIES: A PROPOSED MEASUREMENT TOOL FOR HEALTH CARE DECISION MAKERS
June 5th  2012 – 17th Annual International Meeting, ISPOR Forum Presentation, Washington DC, USA


ISPOR Good Practices For Outcomes Research Index